Daels F Pedro J, Gaizauskas Andrius, Rioja Jorge, Varshney Anil K, Erkan Erkan, Ozgok Yasar, Melekos Michael, de la Rosette Jean J M C H
Department of Urology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
World J Urol. 2015 Jun;33(6):859-64. doi: 10.1007/s00345-014-1382-6. Epub 2014 Aug 26.
This study examined the prevalence of risk factors for urological stone surgery and their possible influence on outcome and complications following ureteroscopy (URS).
The Clinical Research Office of the Endourological Society Ureteroscopy Global Study collected prospective data on consecutive patients with urinary stones treated with URS at centers around the world for 1 year. The prevalence of common comorbidities and anticoagulation therapy and their relationship with complications and age were examined.
Of 11,719 patients, 2,989 patients (25.8%) had cardiovascular disease, including 22.6% with hypertension, and 1,266 patients (10.9%) had diabetes mellitus. Approximately six percent of patients were receiving oral anticoagulation therapy, including aspirin (3.7%) and clopidogrel (0.8%). The prevalence of hypertension and diabetes mellitus and the proportion of patients receiving anticoagulant medication and/or antidiabetes treatment increased with age. Elderly were more likely to develop a postoperative complication when they had diabetes, a cardiovascular disease or received anticoagulation therapy. Post-operative bleeding was higher in patients receiving anticoagulants than those not receiving them (1.1 vs. 0.4%; p < 0.01). Patients with risk factors for stone formation had more complications than those without (4.9 vs. 3.0%, p < 0.001).
This is the first study confirming in a global population that URS can effectively and safely be performed in a population with high comorbidity. The risk of a complication was highest among elderly patients presenting with comorbidities.
本研究调查了泌尿外科结石手术危险因素的患病率及其对输尿管镜检查(URS)后结局和并发症的可能影响。
腔内泌尿外科协会输尿管镜全球研究临床研究办公室收集了世界各地中心连续接受URS治疗的尿路结石患者的前瞻性数据,为期1年。研究了常见合并症和抗凝治疗的患病率及其与并发症和年龄的关系。
在11719例患者中,2989例(25.8%)患有心血管疾病,其中22.6%患有高血压,1266例(10.9%)患有糖尿病。约6%的患者正在接受口服抗凝治疗,包括阿司匹林(3.7%)和氯吡格雷(0.8%)。高血压和糖尿病的患病率以及接受抗凝药物和/或抗糖尿病治疗的患者比例随年龄增加。老年人在患有糖尿病、心血管疾病或接受抗凝治疗时更易发生术后并发症。接受抗凝治疗的患者术后出血率高于未接受抗凝治疗的患者(1.1%对0.4%;p<0.01)。有结石形成危险因素的患者比没有危险因素的患者并发症更多(4.9%对3.0%,p<0.001)。
这是第一项在全球人群中证实URS可在高合并症人群中有效且安全进行的研究。在伴有合并症的老年患者中并发症风险最高。